Erasca (ERAS) Other Accumulated Expenses (2020 - 2026)

Erasca (ERAS) posted Other Accumulated Expenses of $12.1 million for Q1 2026, up 20.92% on a QoQ basis from $10.0 million in Q4 2025, and up 2.31% year-over-year from $11.9 million in Q1 2025.

Erasca (ERAS) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

Erasca's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $12.1 million for Q1 2026.

  • Quarterly Other Accumulated Expenses rose 2.31% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 2.31% YoY) and the FY2025 annual result came in at $10.0 million, down 32.46% from the prior year.
  • Other Accumulated Expenses was $12.1 million for Q1 2026 at Erasca, up from $10.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $14.9 million in Q4 2024 and bottomed at $113000.0 in Q2 2023.
  • A 5-year average of $8.2 million and a median of $10.0 million in 2025 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses tumbled 98.94% — and 2025, when it jumped 9631.15%.
  • Erasca's Other Accumulated Expenses stood at $11.5 million in 2022, then slipped by 23.6% to $8.8 million in 2023, then jumped by 68.94% to $14.9 million in 2024, then sank by 32.46% to $10.0 million in 2025, then increased by 20.92% to $12.1 million in 2026.
  • Business Quant data shows ERAS's Other Accumulated Expenses at $12.1 million in Q1 2026, $10.0 million in Q4 2025, and $11.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn
7 Belite Bio 63.09 Bn 63.09 Bn -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn
9 Revolution Medicines 37.76 Bn 37.76 Bn -
10 Erasca 5.95 Bn 5.71 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 12.15 Mn
Dec 31, 2025 10.05 Mn
Sep 30, 2025 11.16 Mn
Jun 30, 2025 14.37 Mn
Mar 31, 2025 11.87 Mn
Dec 31, 2024 14.87 Mn
Sep 30, 2024 14.23 Mn
Jun 30, 2024 396,000.00
Mar 31, 2024 122,000.00
Dec 31, 2023 8.80 Mn
Sep 30, 2023 9.56 Mn
Jun 30, 2023 113,000.00
Mar 31, 2023 11.49 Mn
Dec 31, 2022 11.52 Mn
Sep 30, 2022 355,000.00
Jun 30, 2022 163,000.00
Mar 31, 2022 8.50 Mn
Dec 31, 2021 483,000.00
Sep 30, 2021 977,000.00
Jun 30, 2021 575,000.00